∗Department of Surgery, Trauma Research Center, School of Medicine, University of Colorado Denver, Aurora, Colorado
†Department of Health Systems, School of Public Health, Management, and Policy, University of Colorado Denver, Aurora, Colorado
‡Ernest E. Moore Shock Trauma Center, Denver Health Medical Center, Denver, Colorado
Received 7 Apr 2022; first review completed 28 Apr 2022; accepted in final form 3 Oct 2022
Address reprint requests to: Margot DeBot, MD, Division of GI, Trauma, and Endocrine, Department of Surgery, Trauma Research Center, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Mail Stop C-320, Room 6102, 12700 East 19th Avenue, Aurora, CO 80045. E-mail: [email protected]
Funding disclosure and conflict of interest statement: The Trauma Research Center has received extramural funding since its inception, mainly from the National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, in the form of program project grants. Other important funded research programs include the Control of Major Bleeding after Trauma (COMBAT; W81XWH-12-2-2008), which was funded by the Department of Defense; a research grant from the Foundation for Women and Girls with Bleeding Disorders (FWGBD); and a series of grants through the Trans-agency Research Consortium for Trauma Induced Coagulopathy (TACTIC; UM1-HL120877) from the National Heart, Lung, and Blood Institute, National Institutes of Health. The current major funding source is an RM-1 grant 1RM1GM131968-01 that runs through May of 2024. We otherwise report no financial or other conflicts of interest.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.shockjournal.com).
